ipamorelin minimal cortisol prolactin The Involvement of in Stress-Related Disorders CJC-1295 Ipamorelin Blend Peptide |

In early research, it was described as the first selective GH secretagogue, showing GH-releasing potency while being more selective than older GHRPs in relation to ACTH and cortisol release. This is the reason Ipamorelin is often compared with, or paired with, CJC-1295

CJC-1295 dosing approaches: CJC-1295 without DAC (Mod GRF 1-29): Dose: 100-200mcg per injection Frequency: 2-3x daily with meals or before bed Works synergistically with Ipamorelin/GHRP Short half-life, requires frequent dosing CJC-1295 with DAC: Dose: 1-2mg per week total Frequency: 2-3 injections weekly (or single weekly) Long-acting, elevated GH for days More convenient than without DAC Example: 5mg vial + 2ml water = 2,500mcg/ml 1mg dose (1,000mcg) = draw 0.40ml 100mcg dose (without DAC) = draw 0.04ml Most people use CJC-1295 WITH DAC for convenience

Because the two peptides engage different receptors on the same cells, laboratories use the blend as a reference GHRH-plus-GHRP combination for studying synergistic GH release

These aren't supplements